EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors

Jinchuan Shi, Gaoxiang Ying, Rongrong Zheng, Zhongdong Zhang

HIV Medicine · 2024-03 · 25 (3) · 361-369

DOI: 10.1111/hiv.13585 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift HIV Medicine, online erschienen am 22.11.2023. Verfasst von Jinchuan Shi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hangzhou Xixi Hospital Zhejiang University School of Medicine, Hangzhou, PR China. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, HIV Integrase Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key projects of the Hangzhou health science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

People living with HIV (PLWH) and receiving antiretroviral therapy (ART) have a goal of achieving and maintaining viral suppression; however, the existence of PLWH that show events of low‐level viremia (LLV) between 50 and 1000 copies/mL and with different virological consequences have been observed. Moreover, some reports indicate that LLV status can lead to residual immune activation and inflammation, leading to a higher occurrence of non‐AIDS‐defining events (nADEs) and other adverse clinical outcomes. Until now, however, published data have shown controversial results that hinder understanding of this phenomenon's actual cause(s) and origin(s). Integrase strand transfer inhibitors (INSTIs)‐based therapies could lead to lower LLV over time and, therefore, more effective virological control.

Objectives

This review aims to assess recent findings to provide a view of the clinical significance and management of low‐level HIV viremia in the era of INSTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsHIV Integrase InhibitorsHumansViremiaClinical RelevanceViral LoadIntegrases

Stichwörter der Autor:innen

HIVantiretroviral therapyclinical managementintegrase strand transfer inhibitorslow-level viremia

Substanzen

Anti-HIV AgentsIntegrasesHIV Integrase Inhibitors

Autor:innen und Institutionen

  • Affiliated Hangzhou Xixi Hospital Zhejiang University School of Medicine, Hangzhou, PR China.

Förderung

  • Key projects of the Hangzhou health science and Technology Plan

Zitieren

APA

Shi, J., Ying, G., Zheng, R., & Zhang, Z. (2024). Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors. HIV Medicine, 25(3), 361-369. https://doi.org/10.1111/hiv.13585

Vancouver

Shi J, Ying G, Zheng R, Zhang Z. Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors. HIV Medicine. 2024;25(3):361-369. doi:10.1111/hiv.13585

BibTeX
@article{Shi2024,
  author = {Shi, Jinchuan and Ying, Gaoxiang and Zheng, Rongrong and Zhang, Zhongdong},
  title = {Clinical significance and management of low‐level HIV viremia in the era of integrase strand transfer inhibitors},
  journal = {HIV Medicine},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {361--369},
  doi = {10.1111/hiv.13585}
}
Kostenlos starten →